<SEC-DOCUMENT>0001140361-22-024158-index.html : 20220627
<SEC-HEADER>0001140361-22-024158.hdr.sgml : 20220627
<ACCEPTANCE-DATETIME>20220627164800
ACCESSION NUMBER:		0001140361-22-024158
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220623
FILED AS OF DATE:		20220627
DATE AS OF CHANGE:		20220627

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SEIDENBERG BETH C
		CENTRAL INDEX KEY:			0001184592

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36548
		FILM NUMBER:		221045264

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Atara Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001604464
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				460920988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD
		STREET 2:		SUITE 900
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-278-8930

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD
		STREET 2:		SUITE 900
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: form4.html

Document 1 - RAW XML: form4.xml

</DOCUMENT>
</SEC-DOCUMENT>